Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Open Access
- 1 October 1994
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (41) , 25646-25654
- https://doi.org/10.1016/s0021-9258(18)47298-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.The Journal of Experimental Medicine, 1992
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathwaysCell, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Angiogenic FactorsScience, 1987
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949